Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer
N.M Tiffany, E.M Wersinger, M Garzotto, T.M BeerVolume:
63
Year:
2004
Language:
english
DOI:
10.1016/j.urology.2003.12.022
File:
PDF, 116 KB
english, 2004